Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Churu Mao

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|January 23, 2026
Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis TreatmentChuru Mao, Shuai Zhan, Zhangyun Fang, et al.
European Journal of Medicinal Chemistry|January 16, 2026
Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancerZhangyun Fang, Shuai Zhan, Churu Mao, et al.
Journal of Chemical Information and Modeling|July 30, 2025
DGMM: A Deep Learning-Genetic Algorithm Framework for Efficient Lead Optimization in Drug DiscoveryJiebin Fang, Churu Mao, Yuchen Zhu, et al.
Journal of Medicinal Chemistry|August 7, 2024
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast CancerXiaoming Chen, Xia Ding, Jiebin Fang, et al.
Journal of Medicinal Chemistry|November 11, 2024
Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor ImmunityChuru Mao, Jiebin Fang, Shijie Zou, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|January 23, 2026
Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis TreatmentChuru Mao, Shuai Zhan, Zhangyun Fang, et al.
European Journal of Medicinal Chemistry|January 16, 2026
Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancerZhangyun Fang, Shuai Zhan, Churu Mao, et al.
Journal of Chemical Information and Modeling|July 30, 2025
DGMM: A Deep Learning-Genetic Algorithm Framework for Efficient Lead Optimization in Drug DiscoveryJiebin Fang, Churu Mao, Yuchen Zhu, et al.
Journal of Medicinal Chemistry|August 7, 2024
Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast CancerXiaoming Chen, Xia Ding, Jiebin Fang, et al.
Journal of Medicinal Chemistry|November 11, 2024
Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor ImmunityChuru Mao, Jiebin Fang, Shijie Zou, et al.
Pageof 1